Benefits and harms of adhesion barriers for abdominal surgery: A systematic review and meta-analysis

The Lancet

Volumn 383, Issue 9911, 2014, Pages 48-59

  Ten Broek, Richard P G ^a   Stommel, Martijn W J ^a   Strik, Chema ^a   Van Laarhoven, Cornelis J H M ^a   Keus, Frederik ^b   Van Goor, Harry ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONATE CARBOXYMETHYLCELLULOSE; ICODEXTRIN; MACROGOL DERIVATIVE; TISSUE ADHESIVE; UNCLASSIFIED DRUG; CARBOXYMETHYLCELLULOSE; GLUCAN; GLUCOSE; OXIDIZED CELLULOSE;

ABDOMINAL PAIN; ABDOMINAL SURGERY; ADHESION BARRIER; CHOLECYSTECTOMY; DEVICE SAFETY; FEMALE INFERTILITY; FOLLOW UP; HUMAN; INGUINAL HERNIA; META ANALYSIS; OPERATION DURATION; OUTCOME ASSESSMENT; PATIENT DECISION MAKING; PELVIC PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; REVIEW; RISK ASSESSMENT; SMALL INTESTINE OBSTRUCTION; SYSTEMATIC REVIEW; TISSUE ADHESION; ABDOMEN; METHODOLOGY; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME;

ABDOMEN; CARBOXYMETHYLCELLULOSE SODIUM; CELLULOSE, OXIDIZED; GLUCANS; GLUCOSE; HUMANS; POLYETHYLENE GLYCOLS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TISSUE ADHESIONS; TREATMENT OUTCOME;

EID: 84892698776     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)61687-6     Document Type: Article

References (71)

1. Fazio VW, Cohen Z, Fleshman JW, et al. Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum 2006; 49: 1-11.
2. Ellis H, Moran BJ, Thompson JN, et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet 1999; 353: 1476-80.
3. Demco L. Pain mapping of adhesions. J Am Assoc Gynecol Laparosc 2004; 11: 181-83.
4. Ørding Olsen K, Juul S, Berndtsson I, Oresland T, Laurberg S. Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology 2002; 122: 15-19.
5. ten Broek RP, Strik C, Issa Y, Bleichrodt RP, van Goor H. Adhesiolysis-related morbidity in abdominal surgery. Ann Surg 2013; 258: 98-106.
6. Sikirica V, Bapat B, Candrilli SD, Davis KL, Wilson M, Johns A. The inpatient burden of abdominal and gynecological adhesiolysis in the US. BMC Surg 2011; 11: 13.
7. van Goor H. Consequences and complications of peritoneal adhesions. Colorectal Dis 2007; 9 (suppl 2): 25-34.
8. Mais V, Ajossa S, Piras B, Guerriero S, Marongiu D, Melis GB. Prevention of de-novo adhesion formation after laparoscopic myomectomy: a randomized trial to evaluate the effectiveness of an oxidized regenerated cellulose absorbable barrier. Hum Reprod 1995; 10: 3133-35.
9. Mais V, Ajossa S, Marongiu D, Peiretti RF, Guerriero S, Melis GB. Reduction of adhesion reformation after laparoscopic endometriosis surgery: a randomized trial with an oxidized regenerated cellulose absorbable barrier. Obstet Gynecol 1995; 86: 512-15.
10. Becker JM, Dayton MT, Fazio VW, et al. Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg 1996; 183: 297-306.
11. Tinelli A, Malvasi A, Guido M, et al. Adhesion formation after intracapsular myomectomy with or without adhesion barrier. Fertil Steril 2011; 95: 1780-85.
12. Schreinemacher MH, ten Broek RP, Bakkum EA, van Goor H, Bouvy ND. Adhesion awareness: a national survey of surgeons. World J Surg 2010; 34: 2805-12.
13. Wilson MS. Practicalities and costs of adhesions. Colorectal Dis 2007; 9 (suppl 2): 60-65.
14. Kumar S, Wong PF, Leaper DJ. Intra-peritoneal prophylactic agents for preventing adhesions and adhesive intestinal obstruction after non-gynaecological abdominal surgery. Cochrane Database Syst Rev 2009; (1): CD005080.
15. Metwally M, Watson A, Lilford R, Vandekerckhove P. Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev 2006; (2): CD001298.
16. Ahmad G, Duffy JM, Farquhar C, et al. Barrier agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev 2008; (2): CD000475.
17. Takeuchi H, Kitade M, Kikuchi I, Shimanuki H, Kumakiri J, Kinoshita K. Adhesion-prevention effects of fibrin sealants after laparoscopic myomectomy as determined by second-look laparoscopy: a prospective, randomized, controlled study. J Reprod Med 2005; 50: 571-77.
18. Larsson B, Lalos O, Marsk L, et al. Effect of intraperitoneal instillation of 32% dextran 70 on postoperative adhesion formation after tubal surgery. Acta Obstet Gynecol Scand 1985; 64: 437-41.
19. Tang CL, Jayne DG, Seow-Choen F, Ng YY, Eu KW, Mustapha N. A randomized controlled trial of 0.5% ferric hyaluronate gel (Intergel) in the prevention of adhesions following abdominal surgery. Ann Surg 2006; 243: 449-55.
20. Keus F, Wetterslev J, Gluud C, van Laarhoven CJ. Evidence at a glance: error matrix approach for overviewing available evidence. BMC Med Res Methodol 2010; 10: 90.
21. Koning GG, Wetterslev J, van Laarhoven CJ, Keus F. The totally extraperitoneal method versus Lichtenstein's technique for inguinal hernia repair: a systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. PLoS One 2013; 8: e52599.
22. Keus F, Gooszen HG, van Laarhoven CJ. Open, small-incision, or laparoscopic cholecystectomy for patients with symptomatic cholecystolithiasis. An overview of Cochrane Hepato-Biliary Group reviews. Cochrane Database Syst Rev 2010; (1): CD008318.
23. Higgins J, Green S. Cochrane Handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration, 2011.
24. Montori VM, Devereaux PJ, Adhikari NK, et al. Randomized trials stopped early for benefit: a systematic review. JAMA 2005; 294: 2203-09.
25. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ, and the GRADE Working Group. What is "quality of evidence" and why is it important to clinicians? BMJ 2008; 336: 995-98.
26. Reference manager (RevMan) [computer program]. Version 5.1. Copenhagen: The Cochrane Collaboration; 2011.
27. Nordic Adhesion Prevention Study Group. The efficacy of Interceed(TC7)* for prevention of reformation of postoperative adhesions on ovaries, fallopian tubes, and fimbriae in microsurgical operations for fertility: a multicenter study. Fertil Steril 1995; 63: 709-14.
28. Azziz R. Microsurgery alone or with INTERCEED Absorbable Adhesion Barrier for pelvic sidewall adhesion re-formation. The INTERCEED (TC7) Adhesion Barrier Study Group II. Surg Gynecol Obstet 1993; 177: 135-39.
29. Franklin RR, and the Ovarian Adhesion Study Group. Reduction of ovarian adhesions by the use of Interceed. Obstet Gynecol 1995; 86: 335-40.
30. van Geldrop H. Interceed absorbable adhesion barrier reduces the formation of postsurgical adhesions after ovarian surgery. In: 50th Annual meeting, American Fertility Society, 1994: 273 (abstract).
31. Greenblatt EM, Casper RF. Adhesion formation after laparoscopic ovarian cautery for polycystic ovarian syndrome: lack of correlation with pregnancy rate. Fertil Steril 1993; 60: 766-70.
32. Keckstein J, Ulrich U, Sasse V, Roth A, Tuttlies F, Karageorgieva E. Reduction of postoperative adhesion formation after laparoscopic ovarian cystectomy. Hum Reprod 1996; 11: 579-82.
33. Li TC, Cooke ID. The value of an absorbable adhesion barrier, Interceed, in the prevention of adhesion reformation following microsurgical adhesiolysis. Br J Obstet Gynaecol 1994; 101: 335-39.
34. Saravelos H, Li TC. Post-operative adhesions after laparoscopic electrosurgical treatment for polycystic ovarian syndrome with the application of Interceed to one ovary: a prospective randomized controlled study. Hum Reprod 1996; 11: 992-97.
35. Sekiba K, and the The Obstetrics and Gynecology Adhesion Prevention Committee. Use of Interceed(TC7) absorbable adhesion barrier to reduce postoperative adhesion reformation in infertility and endometriosis surgery. Obstet Gynecol 1992; 79: 518-22.
36. Beck DE. The role of Seprafilm bioresorbable membrane in adhesion prevention. Eur J Surg Suppl 1997; (577): 49-55.
37. Diamond MP, and the Seprafilm Adhesion Study Group. Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Fertil Steril 1996; 66: 904-10.
38. DupréA, Lefranc A, Buc E, et al. Use of bioresorbable membranes to reduce abdominal and perihepatic adhesions in 2-stage hepatectomy of liver metastases from colorectal cancer: results of a prospective, randomized controlled phase II trial. Ann Surg 2013; 258: 30-36.
39. Hayashi S, Takayama T, Masuda H, et al. Bioresorbable membrane to reduce postoperative small bowel obstruction in patients with gastric cancer: a randomized clinical trial. Ann Surg 2008; 247: 766-70.
40. Inoue M, Uchida K, Miki C, Kusunoki M. Efficacy of Seprafilm for reducing reoperative risk in pediatric surgical patients undergoing abdominal surgery. J Pediatr Surg 2005; 40: 1301-06.
41. Kusunoki M, Ikeuchi H, Yanagi H, et al. Bioresorbable hyaluronatecarboxymethylcellulose membrane (Seprafilm) in surgery for rectal carcinoma: a prospective randomized clinical trial. Surg Today 2005; 35: 940-45.
42. Park CM, Lee WY, Cho YB, et al. Sodium hyaluronate-based bioresorbable membrane (Seprafilm) reduced early postoperative intestinal obstruction after lower abdominal surgery for colorectal cancer: the preliminary report. Int J Colorectal Dis 2009; 24: 305-10.
43. Salum M, Wexner SD, Nogueras JJ, et al., and the Program Directors Association in Colon and Rectal Surgery. Does sodium hyaluronateand carboxymethylcellulose-based bioresorbable membrane (Seprafilm) decrease operative time for loop ileostomy closure? Tech Coloproctol 2006; 10: 187-90, discussion 190-91.
44. Vrijland WW, Tseng LN, Eijkman HJ, et al. Fewer intraperitoneal adhesions with use of hyaluronic acid-carboxymethylcellulose membrane: a randomized clinical trial. Ann Surg 2002; 235: 193-99.
45. van der Wal JB, Iordens GI, Vrijland WW, Van Veen RN, Lange J, Jeekel J. Adhesion prevention during laparotomy: long-term follow-up of a randomized clinical trial. Ann Surg 2011; 253: 1118-21.
46. Catena F, Ansaloni L, Saverio S, et al. POPA study: prevention of postoperative abdominal adhesions by icodextrin 4% solution after laparotomy for adhesive small bowel obstruction. A prospective randomized controlled trial. J Gastrointest Surg 2012; 16: 382-88.
47. diZerega GS, Verco SJ, Young P, et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Hum Reprod 2002; 17: 1031-38.
48. Kössi J, Grönlund S, Uotila-Nieminen M, Crowe A, Knight A, Keränen U. The effect of 4% icodextrin solution on adhesiolysis surgery time at the Hartmann's reversal: a pilot, multicentre, randomized control trial vs lactated Ringer's solution. Colorectal Dis 2009; 11: 168-72.
49. Trew G, Pistofidis G, Pados G, et al. Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomized study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery. Hum Reprod 2011; 26: 2015-27.
50. Banasiewicz T, Karon J, Horbacka K, et al. SprayShield Adhesion Barrier System in the prevention of the abdominal adhesions-short series prospective, multi-center, randomized, single blind study. Colorectal Disease Conference: 6th Scientific and Annual Meeting of the European Society of Coloproctology, 2011; 56 (abstract).
51. De Wilde RL. Post market study for an adhesion barrier following laparoscopic myomectomy. http://clinicaltrials.gov/show/ NCT00891657. (accessed Jan 1, 2013).
52. Johns DA, Ferland R, Dunn R. Initial feasibility study of a sprayable hydrogel adhesion barrier system in patients undergoing laparoscopic ovarian surgery. J Am Assoc Gynecol Laparosc 2003; 10: 334-38.
53. Mettler L, Hucke J, Bojahr B, Tinneberg HR, Leyland N, Avelar R. A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy. Hum Reprod 2008; 23: 1093-100.
54. Mettler L, Audebert A, Lehmann-Willenbrock E, Schive-Peterhansl K, Jacobs VR. A randomized, prospective, controlled, multicenter clinical trial of a sprayable, site-specific adhesion barrier system in patients undergoing myomectomy. Fertil Steril 2004; 82: 398-404.
55. Tjandra JJ, Chan MK. A sprayable hydrogel adhesion barrier facilitates closure of defunctioning loop ileostomy: a randomized trial. Dis Colon Rectum 2008; 51: 956-60.
56. ten Broek RP, Schreinemacher MH, Jilesen AP, Bouvy N, Bleichrodt RP, van Goor H. Enterotomy risk in abdominal wall repair: a prospective study. Ann Surg 2012; 256: 280-87.
57. Ten Broek RP, Kok-Krant N, Verhoeve HR, van Goor H, Bakkum EA. Efficacy of polyethylene glycol adhesion barrier after gynecological laparoscopic surgery: results of a randomized controlled pilot study. Gynecol Surg 2012; 9: 29-35.
58. Linsky CB, Diamond MP, Cunningham T, Constantine B, DeCherney AH, diZerega GS. Adhesion reduction in the rabbit uterine horn model using an absorbable barrier, TC-7. J Reprod Med 1987; 32: 17-20.
59. Dimitrijevich SD, Tatarko M, Gracy RW, et al. In vivo degradation of oxidized, regenerated cellulose. Carbohydr Res 1990; 198: 331-41.
60. Burns JW, Colt MJ, Burgees LS, Skinner KC. Preclinical evaluation of Seprafilm bioresorbable membrane. Eur J Surg Suppl 1997; (577): 40-48.
61. Hosie K, Gilbert JA, Kerr D, Brown CB, Peers EM. Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin. Drug Deliv 2001; 8: 9-12.
62. Verco SJ, Peers EM, Brown CB, Rodgers KE, Roda N, diZerega G. Development of a novel glucose polymer solution (icodextrin) for adhesion prevention: pre-clinical studies. Hum Reprod 2000; 15: 1764-72.
63. Dunn R, Lyman MD, Edelman PG, Campbell PK. Evaluation of the SprayGel adhesion barrier in the rat cecum abrasion and rabbit uterine horn adhesion models. Fertil Steril 2001; 75: 411-16.
64. Spanjersberg WR, Reurings J, Keus F, van Laarhoven CJ. Fast track surgery versus conventional recovery strategies for colorectal surgery. Cochrane Database Syst Rev 2011; (2): CD007635.
65. Diamond MP, Wexner SD, diZereg GS, et al. Adhesion prevention and reduction: current status and future recommendations of a multinational interdisciplinary consensus conference. Surg Innov 2010; 17: 183-88.
66. Wiseman DM, Gottlick-Iarkowski L, Kamp L. Effect of different barriers of oxidized regenerated cellulose (ORC) on cecal and sidewall adhesions in the presence and absence of bleeding. J Invest Surg 1999; 12: 141-46.
67. Wiseman DM, Gottlick LE, Diamond MP. Effect of thrombin-induced hemostasis on the efficacy of an absorbable adhesion barrier. J Reprod Med 1992; 37: 766-70.
68. Menzies D, Pascual MH, Walz MK, et al., and the ARIEL Registry. Use of icodextrin 4% solution in the prevention of adhesion formation following general surgery: from the multicentre ARIEL Registry. Ann R Coll Surg Engl 2006; 88: 375-82.
69. Sutton C, Minelli L, Garcia E, et al. Use of icodextrin 4% solution in the reduction of adhesion formation after gynaecological surgery. Gynecol Surg 2005; 2: 287-96.
70. Tzianabos AO, Cisneros RL, Gershkovich J, et al. Effect of surgical adhesion reduction devices on the propagation of experimental intra-abdominal infection. Arch Surg 1999; 134: 1254-59.
71. De Wilde RL, Brölmann H, Koninckx PR, et al., and the Anti-Adhesions in Gynecology Expert Panel (ANGEL). Prevention of adhesions in gynaecological surgery: the 2012 European field guideline. Gynecol Surg 2012; 9: 365-68.